Skip to main content
. Author manuscript; available in PMC: 2023 Jul 21.
Published in final edited form as: Cell. 2022 Jul 13;185(15):2770–2788. doi: 10.1016/j.cell.2022.06.035

Figure 3: Vaccines, a bridge to cure?

Figure 3:

While there are many barriers to natural immune responses to cancer, we propose that focusing on four pillars (innate and adaptive immune cells, antigen targets, delivery strategies and co-therapies) will help vaccines become a bridge from cancer to immune-based cure.